Our newest portfolio stock backed off its recent 52-week high — so we're buying more
Related
Healthy Returns: RFK Jr.’s Covid vaccine recommendation chan...
1 month ago
198
UnitedHealth Group shares plunge 18% on reported DOJ probe i...
1 month ago
232
Kennedy sidesteps vaccine questions: ‘I don’t think people s...
1 month ago
201
Hims & Hers gives weak outlook but says more collaborations ...
2 months ago
277
Eli Lilly sales soar 45% on weight loss drug demand, but dru...
2 months ago
208
Oracle engineers caused days-long software outage at U.S. ho...
2 months ago
208
23andMe bankruptcy: With America's DNA put on sale, market p...
3 months ago
267
Life science stocks are under pressure due to possible NIH f...
3 months ago
228
Bristol Myers' stock decline in response to weak guidance is...
4 months ago
254
Eli Lilly posts mixed quarter even as demand for weight loss...
4 months ago
215
23andMe is exploring strategic alternatives, looking to rais...
5 months ago
234
We're lightening up on a rallying stock that's grown too big...
5 months ago
218
Prostavive Reviews: Top Benefits, Natural Solution and How P...
7 months ago
755
Trump says RFK Jr. plan to remove fluoride from public water...
8 months ago
255
CVS to replace CEO Karen Lynch with exec David Joyner as pro...
8 months ago
283
This government-backed startup is growing blood to help figh...
9 months ago
288
4 ways how cancer care has improved in India
1 year ago
407
Trending
Popular
Our Motorola Razr+ 2025 video review is out
3 days ago
146
‘Sarzameen’ Teaser: Gripping action-drama set in Kashmir
6 days ago
123
© Rclipse.Com 2025. All rights are reserved